# FDA recall D-0437-2024

> **Lupin Pharmaceuticals Inc.** · Class II · drug recall initiated 2024-03-21.

## Product

Rifampin Capsules USP, 300mg, 30-count bottles, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202, Manufactured by: Lupin Limited Aurangabad 431 210 India, NDC 6818-0659-06

## Reason for recall

Subpotent Drug

## Distribution

Nationwide within the United States

## Key facts

- **Recall number:** D-0437-2024
- **Recalling firm:** Lupin Pharmaceuticals Inc.
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2024-03-21
- **Report date:** 2024-04-17
- **Termination date:** 2025-04-04

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Baltimore, MD, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0437-2024

## Citation

> AI Analytics. FDA recall D-0437-2024. Retrieved 2026-06-26 from https://api.ai-analytics.org/recall/D-0437-2024. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*